Reaction Details Report a problem with these data
Target
Free fatty acid receptor 1
Ligand
BDBM300895
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
15.0±n/a nM
Citation
Liang, Y; Demarest, KT GPR40 agonists in anti-diabetic drug combinations US Patent US10195178 Publication Date 2/5/2019
More Info.:
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
Inhibitor
Name:
BDBM300895
Synonyms:
(3S)-3-(4-((3-(6-Chloro-3- methylpyridin-2- yl)benzo[b]thiophen-5- yl)methoxy)phenyl) hex-4-ynoic acid | US10131648, Compound 93 | US10195178, Compound 93 | US9790198, Compound 93
Type:
Small organic molecule
Emp. Form.:
C27H22ClNO3S
Mol. Mass.:
475.986
SMILES:
CC#C[C@@H](CC(O)=O)c1ccc(OCc2ccc3scc(-c4nc(Cl)ccc4C)c3c2)cc1 |r|